Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Kimbrough CL"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hailey JR; 1 Covance Laboratories, Inc., Chantilly, Virginia, USA., Maleeff BE; 2 GlaxoSmithKline, King of Prussia, Pennsylvania, USA., Thomas HC; 3 Experimental Pathology Laboratories, Collegeville, Pennsylvania, USA., Pearse G; 4 GlaxoSmithKline, Ware, Hertfordshire, United Kingdom., Klapwijk JC; 4 GlaxoSmithKline, Ware, Hertfordshire, United Kingdom., Cristofori PG; 4 GlaxoSmithKline, Ware, Hertfordshire, United Kingdom., Berridge B; 2 GlaxoSmithKline, King of Prussia, Pennsylvania, USA., Kimbrough CL; 5 PAREXEL International, Durham, North Carolina, USA., Parker GA; 6 Charles River Laboratories, Durham, North Carolina, USA., Morton D; 7 Pfizer, Groton, Connecticut, USA., Elmore S; 8 National Institute of Environmental Sciences, Research Triangle Park, North Carolina, USA., Hardisty JF; 9 Experimental Pathology Laboratories, Research Triangle Park, North Carolina, USA., Dybdal NO; 10 Genentech, Inc., South San Francisco, California, USA., Rehagen DA; 11 MPI Research, Mattawan, Michigan, USA., Fikes JD; 12 Biogen Idec, Cambridge, Massachusetts, USA., Lamb M; 12 Biogen Idec, Cambridge, Massachusetts, USA., Biddle K; 7 Pfizer, Groton, Connecticut, USA., Buetow BS; 13 Pfizer, San Diego, California, USA., Carreira V; 14 Vet Path Services, Inc., Mason, Ohio, USA., Nyska A; 15 Sackler School of Medicine, Tel Aviv University, Timrat, Israel., Tripathi NK; 16 Covance Laboratories, Inc., Madison, Wisconsin, USA., Workman HC; 17 Covance Laboratories, Inc., Greenfield, Indiana, USA., Bienvenu JG; 18 Charles Rivers Laboratories, Montreal, Quebec, Canada., Brees I; 19 Novartis Pharma AG, Basel, Switzerland., Turk JR; 20 Amgen, Thousand Oaks, California, USA., Adler RR; 2 GlaxoSmithKline, King of Prussia, Pennsylvania, USA.
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2017 Dec; Vol. 45 (8), pp. 1055-1066.
Autor:
Hailey JR; 1 Covance Laboratories, Inc., Chantilly, Virginia, USA., Maleeff BE; 2 GlaxoSmithKline, King of Prussia, Pennsylvania, USA., Thomas HC; 3 Experimental Pathology Laboratories, Collegeville, Pennsylvania, USA., Pearse G; 4 GlaxoSmithKline, Ware, Hertfordshire, United Kingdom., Klapwijk JC; 4 GlaxoSmithKline, Ware, Hertfordshire, United Kingdom., Cristofori PG; 4 GlaxoSmithKline, Ware, Hertfordshire, United Kingdom., Berridge B; 2 GlaxoSmithKline, King of Prussia, Pennsylvania, USA., Kimbrough CL; 5 PAREXEL International, Durham, North Carolina, USA., Parker GA; 6 Charles River Laboratories, Durham, North Carolina, USA., Morton D; 7 Pfizer, Groton, Connecticut, USA., Elmore S; 8 National Institute of Environmental Sciences, Research Triangle Park, North Carolina, USA., Hardisty JF; 9 Experimental Pathology Laboratories, Research Triangle Park, North Carolina, USA., Dybdal NO; 10 Genentech, Inc., South San Francisco, California, USA., Rehagen DA; 11 MPI Research, Inc., Mattawan, Michigan, USA., Fikes JD; 12 Biogen Idec, Cambridge, Massachusetts, USA., Lamb M; 12 Biogen Idec, Cambridge, Massachusetts, USA., Biddle K; 7 Pfizer, Groton, Connecticut, USA., Buetow BS; 13 Pfizer, San Diego, California, USA., Carreira V; 14 Vet Path Services, Inc., Mason, Ohio, USA., Nyska A; 15 Sackler School of Medicine, Tel Aviv University, Timrat, Israel., Tripathi NK; 16 Covance Laboratories, Inc., Madison, Wisconsin, USA., Workman HC; 17 Covance Laboratories, Inc., Greenfield, Indiana, USA., Bienvenu JG; 18 Charles Rivers Laboratories, Montreal, Quebec, Canada., Brees I; 19 Novartis Pharma AG, Basel, Switzerland., Turk JR; 20 Amgen, Thousand Oaks, California, USA., Adler RR; 2 GlaxoSmithKline, King of Prussia, Pennsylvania, USA.
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2017 Dec; Vol. 45 (8), pp. 1043-1054. Date of Electronic Publication: 2017 Nov 26.
Autor:
Ennulat D; 1 GlaxoSmithKline, Safety Assessment, King of Prussia, Pennsylvania, USA., Lynch KM; 1 GlaxoSmithKline, Safety Assessment, King of Prussia, Pennsylvania, USA., Kimbrough CL; 2 GlaxoSmithKline, Statistical Sciences, Research Triangle Park, North Carolina, USA.; 3 PAREXEL International, Durham, North Carolina, USA., Mirabile RC; 1 GlaxoSmithKline, Safety Assessment, King of Prussia, Pennsylvania, USA., Rehm S; 1 GlaxoSmithKline, Safety Assessment, King of Prussia, Pennsylvania, USA.
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2017 Feb; Vol. 45 (2), pp. 296-301. Date of Electronic Publication: 2016 Dec 22.
Autor:
Cullen JM; North Carolina State University, College of Veterinary Medicine, Raleigh, North Carolina, USA jcullen@ncsu.edu., Faiola B; GlaxoSmithKline, Safety Assessment, Research Triangle Park, North Carolina, USA., Melich DH; GlaxoSmithKline, Safety Assessment, Research Triangle Park, North Carolina, USA., Peterson RA; GlaxoSmithKline, Safety Assessment, Research Triangle Park, North Carolina, USA., Jordan HL; GlaxoSmithKline, Safety Assessment, Research Triangle Park, North Carolina, USA., Kimbrough CL; GlaxoSmithKline, Statistical Sciences, Research Triangle Park, North Carolina, USA., Miller RT; GlaxoSmithKline, Safety Assessment, Research Triangle Park, North Carolina, USA.
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2016 Oct; Vol. 44 (7), pp. 987-97. Date of Electronic Publication: 2016 Aug 12.
Autor:
Spector NL; Department of Medicine, Duke Cancer Center, Duke University Medical Center, Durham, North Carolina, United States of America., Robertson FC; Department of Medicine, Duke Cancer Center, Duke University Medical Center, Durham, North Carolina, United States of America., Bacus S; Targeted Molecular Diagnostics/Quintiles, Westmont, Illinois, United States of America., Blackwell K; Department of Medicine, Duke Cancer Center, Duke University Medical Center, Durham, North Carolina, United States of America., Smith DA; GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America., Glenn K; GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America., Cartee L; GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America., Harris J; Pivot Oncology Consulting, Durham, North Carolina, United States of America., Kimbrough CL; PAREXEL International, Durham, North Carolina, United States of America., Gittelman M; Breast Cancer Specialists, Allentown, Pennsylvania, United States of America., Avisar E; Department of Surgery, University of Miami School of Medicine, Miami, Florida, United States of America., Beitsch P; Dallas Surgical Group, Dallas, Texas, United States of America., Koch KM; GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America.
Publikováno v:
PloS one [PLoS One] 2015 Nov 16; Vol. 10 (11), pp. e0142845. Date of Electronic Publication: 2015 Nov 16 (Print Publication: 2015).